What is the frequency of major chromosome abnormalities in a population-based diagnostic data set of genomic tests performed on miscarriage, fetal and infant samples in a state with >73 000 annual births?
The overall frequency of major chromosome abnormalities in the entire cohort was 28.2% (2493/8826), with a significant decrease in the detection of major chromosome abnormalities with later developmental stage, from 50.9% to 21.3% to 15.6% of tests in the miscarriage, prenatal and postnatal cohorts, respectively.
Over the past decade, technological advances have revolutionized genomic testing at every stage of reproduction. Chromosomal microarrays (CMAs) are now the gold standard of chromosome assessment in prenatal diagnosis and pediatrics.A population-based cohort study including all chromosome analysis was performed in the Australian state of Victoria during a 24-month period from January 2015 to December 2016.
JTC-801 |
A8456-10 |
ApexBio |
10 mg |
EUR 48 |
|
Description: KOR-3 (NOP) receptor antagonist |
JTC-801 |
A8456-5 |
ApexBio |
5 mg |
EUR 36 |
|
Description: KOR-3 (NOP) receptor antagonist |
JTC-801 |
A8456-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 48 |
|
Description: KOR-3 (NOP) receptor antagonist |
JTC-801 |
A8456-50 |
ApexBio |
50 mg |
EUR 169 |
|
Description: KOR-3 (NOP) receptor antagonist |
(+)-MK 801 Maleate |
A8896-10 |
ApexBio |
10 mg |
EUR 38 |
|
Description: Potent NMDA antagonist |
(+)-MK 801 Maleate |
A8896-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 44 |
|
Description: Potent NMDA antagonist |
(+)-MK 801 Maleate |
A8896-50 |
ApexBio |
50 mg |
EUR 149 |
|
Description: Potent NMDA antagonist |
NaV1.7 Blocker-801 |
T28132-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: NaV1.7 Blocker-801 |
NaV1.7 Blocker-801 |
T28132-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: NaV1.7 Blocker-801 |
NaV1.7 Blocker-801 |
T28132-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: NaV1.7 Blocker-801 |
NaV1.7 Blocker-801 |
T28132-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: NaV1.7 Blocker-801 |
NaV1.7 Blocker-801 |
T28132-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: NaV1.7 Blocker-801 |
SEPARASE (Ab-801) Antibody |
E11-0086B |
EnoGene |
100μg |
EUR 225 |
Description: Available in various conjugation types. |
(+)-MK 801 Hydrogen Maleate |
B2326-25 |
Biovision |
each |
EUR 418.8 |
(+)-MK 801 Hydrogen Maleate |
B2326-5 |
Biovision |
each |
EUR 157.2 |
(-)-MK 801 Hydrogen Maleate |
B2327-25 |
Biovision |
each |
EUR 418.8 |
(-)-MK 801 Hydrogen Maleate |
B2327-5 |
Biovision |
each |
EUR 157.2 |
SEPARASE (Ab-801) Antibody |
8B0086 |
AAT Bioquest |
50ug |
EUR 368 |
Description: SEPARASE (Ab-801) Antibody |
JTC-801 free base |
T6553L-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: JTC-801 free base |
JTC-801 free base |
T6553L-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: JTC-801 free base |
JTC-801 free base |
T6553L-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: JTC-801 free base |
JTC-801 free base |
T6553L-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: JTC-801 free base |
JTC-801 free base |
T6553L-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: JTC-801 free base |
HTLV2 env 801 Antibody |
GWB-75D477 |
GenWay Biotech |
0.025 mg |
Ask for price |
Olr801 (Myc-DDK-tagged ORF) - Rat olfactory receptor 801 (Olr801), (10 ug) |
RR213594 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNCH0801-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNCH0801-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
801-D [PLA-801D] Cells Complete Medium |
CM-0250-125mL4 |
Elabscience Biotech |
125 mL×4 |
EUR 98 |
Description: Complete Growth Medium |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC700801-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF770 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC700801-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF770 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC810801-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF680R conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC810801-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF680R conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC800801-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF680 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC800801-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF680 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC550801-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF555 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC550801-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF555 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC430801-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF543 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC430801-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF543 conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC610801-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF660R conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC610801-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF660R conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC050801-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF405M conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNC050801-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), CF405M conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNCA0801-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), APC conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNCAP0801-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNCAP0801-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNCP0801-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), PerCP conjugate, Concentration: 0.1mg/mL |
PSA (Prostate Specific Antigen)(KLK3/801) Antibody |
BNCR0801-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against PSA (Prostate Specific Antigen)(KLK3/801), RPE conjugate, Concentration: 0.1mg/mL |
Anti-Human PSA Antibody | MPSA-80A-801 |
MPSA-80A-801 |
Immunology Consultants Laboratory |
1.0 mg |
EUR 334 |
Description: Anti-Human PSA Antibody ; MPSA-80A-801 ; Immunology Consultants Laboratory Host: Mouse Format: Purified Monoclonal Product Type: Primary Antibody Antibody Clonality: Monoclonal |
STFN 801-DIA 100-B7541 AC Signs |
223678 |
BRADY NV |
Card of 1 Pictogram(s) |
EUR 2.68 |
Description: Description Dutch: Verbodspictogram - Verboden contact aan te leggen - CONTACT; Description French: Défense de mettre le contact |
STFN 801-DIA 200-B7541 AC Signs |
223679 |
BRADY NV |
Card of 1 Pictogram(s) |
EUR 3.44 |
Description: Description Dutch: Verbodspictogram - Verboden contact aan te leggen - CONTACT; Description French: Défense de mettre le contact |
STFN 801-DIA 315-B7541 AC Signs |
223680 |
BRADY NV |
Card of 1 Pictogram(s) |
EUR 6.08 |
Description: Description Dutch: Verbodspictogram - Verboden contact aan te leggen - CONTACT; Description French: Défense de mettre le contact |
STFN 801-DIA 100-B7527 AC Signs |
223681 |
BRADY NV |
Card of 1 Pictogram(s) |
EUR 5.99 |
Description: Description Dutch: Verbodspictogram - Verboden contact aan te leggen - CONTACT; Description French: Défense de mettre le contact |
STFN 801-DIA 200-B7527 AC Signs |
223682 |
BRADY NV |
Card of 1 Pictogram(s) |
EUR 11.21 |
Description: Description Dutch: Verbodspictogram - Verboden contact aan te leggen - CONTACT; Description French: Défense de mettre le contact |
STFN 801-DIA 315-B7527 AC Signs |
223683 |
BRADY NV |
Card of 1 Pictogram(s) |
EUR 27.38 |
Description: Description Dutch: Verbodspictogram - Verboden contact aan te leggen - CONTACT; Description French: Défense de mettre le contact |
STFN 801-DIA 315-B7525 AC Signs |
223686 |
BRADY NV |
Card of 1 Pictogram(s) |
EUR 30.12 |
Description: Description Dutch: Verbodspictogram - Verboden contact aan te leggen - CONTACT; Description French: Défense de mettre le contact |
801-D [PLA-801D] Cells Complete Medium |
CM-0250 |
Elabscience Biotech |
125mL×4 |
EUR 98 |
|
Description: Cell lines complete growth medium |
PSA (Prostate Specific Antigen)(KLK3/801), 1mg/mL |
BNUM0801-50 |
Biotium |
50uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), 0.2mg/mL |
BNUB0801-100 |
Biotium |
100uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), 0.2mg/mL |
BNUB0801-500 |
Biotium |
500uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA); Clone KLK3/801 (Concentrate) |
RA0009-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 60.07 |
Prostate Specific Antigen (PSA); Clone KLK3/801 (Concentrate) |
RA0009-C.5 |
ScyTek Laboratories |
0.5 ml |
EUR 200.66 |
Recombinant Neisseria Gonorrhoeae lptD Protein (aa 1-801) |
VAng-Wyb2182-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Neisseria Gonorrhoeae (strain ATCC 700825 / FA 1090) LPS-assembly protein lptD, recombinant protein. |
Recombinant Streptococcus Pyogenes ftsK Protein (aa 1-801) |
VAng-Cr8109-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Streptococcus Pyogenes serotype M18 DNA translocase FtsK (ftsK), recombinant protein. |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNCAP1256-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNCAP1256-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNCH1256-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNCH1256-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC701256-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF770 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC701256-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF770 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC801256-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF680 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC801256-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF680 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC811256-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF680R conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC811256-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF680R conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC551256-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF555 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC551256-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF555 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC431256-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF543 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC431256-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF543 conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC611256-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF660R conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC611256-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF660R conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC051256-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF405M conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNC051256-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF405M conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNCA1256-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), APC conjugate, Concentration: 0.1mg/mL |
Endostatin (COL18A1) (801-850) rabbit polyclonal antibody, Aff - Purified |
AP31363PU-N |
Origene Technologies GmbH |
50 µl |
Ask for price |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNCP1256-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), PerCP conjugate, Concentration: 0.1mg/mL |
Prostate Specific Antigen (PSA) (KLK3/801 + KLK3/1248) Antibody |
BNCR1256-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), RPE conjugate, Concentration: 0.1mg/mL |
Lenti ORF clone of Olr801 (mGFP-tagged ORF) - Rat olfactory receptor 801 (Olr801), (10 ug) |
RR213594L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF particles, Olfr801 (GFP-tagged) - Mouse olfactory receptor 801 (Olfr801), 200ul, >10^7 TU/mL |
MR213085L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF clone of Olr801 (Myc-DDK-tagged ORF) - Rat olfactory receptor 801 (Olr801), (10 ug) |
RR213594L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Anti-Prostate Specific Antigen Antibody Clone KLK3/801, Unconjugated-100ug |
354-MSM2-P1 |
EnQuireBio |
100ug |
EUR 513.6 |
PSA (Prostate Specific Antigen)(KLK3/801), CF594 conjugate, 0.1mg/mL |
BNC940801-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF594 conjugate, 0.1mg/mL |
BNC940801-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), 1mg/mL |
BNUM1256-50 |
Biotium |
50uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF488A conjugate, 0.1mg/mL |
BNC880801-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF488A conjugate, 0.1mg/mL |
BNC880801-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF647 conjugate, 0.1mg/mL |
BNC470801-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF647 conjugate, 0.1mg/mL |
BNC470801-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF568 conjugate, 0.1mg/mL |
BNC680801-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF568 conjugate, 0.1mg/mL |
BNC680801-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF405S conjugate, 0.1mg/mL |
BNC040801-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF405S conjugate, 0.1mg/mL |
BNC040801-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF640R conjugate, 0.1mg/mL |
BNC400801-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), CF640R conjugate, 0.1mg/mL |
BNC400801-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), Biotin conjugate, 0.1mg/mL |
BNCB0801-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PSA (Prostate Specific Antigen)(KLK3/801), Biotin conjugate, 0.1mg/mL |
BNCB0801-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), 0.2mg/mL |
BNUB1256-100 |
Biotium |
100uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), 0.2mg/mL |
BNUB1256-500 |
Biotium |
500uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Lenti ORF particles, Olfr801 (Myc-DDK-tagged) - Mouse olfactory receptor 801 (Olfr801), 200ul, >10^7 TU/mL |
MR213085L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, Olr801 (GFP-tagged ORF) - Rat olfactory receptor 801 (Olr801), 200ul, >10^7 TU/mL |
RR213594L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, Olr801 (Myc-DDK-tagged ORF) - Rat olfactory receptor 801 (Olr801), 200ul, >10^7 TU/mL |
RR213594L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Anti-Prostate Specific Antigen Antibody Clone KLK3/801 + KLK3/1248, Unconjugated-100ug |
354-MSM6-P1 |
EnQuireBio |
100ug |
EUR 513.6 |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Biotin conjugate, 0.1mg/mL |
BNCB1256-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), Biotin conjugate, 0.1mg/mL |
BNCB1256-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF488A conjugate, 0.1mg/mL |
BNC881256-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF488A conjugate, 0.1mg/mL |
BNC881256-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF568 conjugate, 0.1mg/mL |
BNC681256-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF568 conjugate, 0.1mg/mL |
BNC681256-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF647 conjugate, 0.1mg/mL |
BNC471256-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF647 conjugate, 0.1mg/mL |
BNC471256-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF405S conjugate, 0.1mg/mL |
BNC041256-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF405S conjugate, 0.1mg/mL |
BNC041256-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF640R conjugate, 0.1mg/mL |
BNC401256-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF640R conjugate, 0.1mg/mL |
BNC401256-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF594 conjugate, 0.1mg/mL |
BNC941256-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Prostate Specific Antigen (PSA)(KLK3/801 + KLK3/1248), CF594 conjugate, 0.1mg/mL |
BNC941256-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Lenti ORF clone of Olfr801 (mGFP-tagged) - Mouse olfactory receptor 801 (Olfr801) |
MR213085L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Monoclonal Prostate Specific Antigen (PSA) Antibody - With BSA and Azide, Clone: KLK3/801 |
AMM00914G |
Leading Biology |
0.05mg |
EUR 475.2 |
Description: A Monoclonal antibody against Human Prostate Specific Antigen (PSA) - With BSA and Azide. The antibodies are raised in Mouse and are from clone KLK3/801. This antibody is applicable in IHC, IF, FC |
Monoclonal Prostate Specific Antigen (PSA) Antibody - Without BSA and Azide, Clone: KLK3/801 |
AMM00915G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human Prostate Specific Antigen (PSA) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone KLK3/801. This antibody is applicable in IHC, IF, FC |
Lenti ORF clone of Olfr801 (Myc-DDK-tagged) - Mouse olfactory receptor 801 (Olfr801) |
MR213085L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Monoclonal Prostate Specific Antigen (PSA) Antibody - Without BSA and Azide, Clone: KLK3/801 + KLK3/1248 |
AMM00919G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human Prostate Specific Antigen (PSA) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone KLK3/801 + KLK3/1248. This antibody is applicable in IHC-P, IF, FC |
10% GeBaGel, 10 wells |
10G-0010-10 |
GEBA |
10 X GeBaGels, 10%, 10 wells |
EUR 64 |
10% GeBaGel, 10 wells |
10G-0010-2 |
GEBA |
2 X GeBaGels, 10%, 10 wells |
EUR 13 |
IL-10/Interleukin-10 |
E21-697 |
EnoGene |
10ug |
EUR 225 |
|
Description: Recombinant Mouse Interleukin-10 is produced by our E.coli expression system and the target gene encoding Ser19-Ser178 is expressed. |
10-DAB (10-Deacetylbaccatin) |
A4395-100 |
ApexBio |
100mg |
EUR 49 |
|
Description: Precursor of antitumor compound Palitaxel and Docetaxel |
10-DAB (10-Deacetylbaccatin) |
A4395-200 |
ApexBio |
200mg |
EUR 78 |
|
Description: Precursor of antitumor compound Palitaxel and Docetaxel |
10-DAB (10-Deacetylbaccatin) |
A4395-25 |
ApexBio |
25 mg |
EUR 616.8 |
Description: 10-DAB (also known as 10-Deacetylbaccatin) is an intermediate used for the preparation of taxol, an anti-leukemic and tumor-inhibiting agent isolated from the inner bark of the Pacific yew tree Taxus brevifolia as well as other species of the genus Taxus. |
10-DAB (10-Deacetylbaccatin) |
A4395-5 |
ApexBio |
5 mg |
EUR 199.2 |
Description: 10-DAB (also known as 10-Deacetylbaccatin) is an intermediate used for the preparation of taxol, an anti-leukemic and tumor-inhibiting agent isolated from the inner bark of the Pacific yew tree Taxus brevifolia as well as other species of the genus Taxus. |
All samples obtained via invasive prenatal diagnosis and postnatal samples from pregnancy tissue and infants ≤12 months of age were included.A research collaboration of screening and diagnostic units in the Australian state of Victoria was formed (the Perinatal Record Linkage collaboration), capturing all instances of prenatal and postnatal chromosome testing performed in the state.